Sponsor

Diamyd Medical AB

Sweden P. O. Box 7349, 103 90 Stockholm, Sweden

About the sponsor

Diamyd Medical AB focuses its clinical research on Type 1 diabetes, with studies centered on preserving beta cell function and supporting glycemic control in people with recent diagnosis or elevated disease risk.

Recent-onset Type 1 diabetes
Preservation of insulin production
Beta cell function
Glycemic control

The sponsor’s work includes adolescents and adults with HLA DR3-DQ2 and GAD65 antibodies, reflecting a strong interest in immune-defined subgroups within autoimmune diabetes.

About Specializations

Diamyd Medical AB runs clinical trials in conditions such as Type 1 diabetes mellitus, among others.

Type 1 diabetes mellitus

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

2 clinical trials

Type 1 diabetes mellitus

Not recruiting

Study on the Safety and Feasibility of Diamyd (Glutamate Decarboxylase 2) for Individuals Aged 8-17 at Risk for Type 1 Diabetes with HLA DR3-DQ2 Haplotype

InvestigationalNo placebo